Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Nadejda Beliakova-Bethell

    Address9500 Gilman Drive #0679
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, Richman DD, Spina CA. Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology. 2017 Aug; 508:127-133. PMID: 28527342.
        View in: PubMed
      2. White CH, Moesker B, Beliakova-Bethell N, Martins LJ, Spina CA, Margolis DM, Richman DD, Planelles V, Bosque A, Woelk CH. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. PLoS Pathog. 2016 Nov; 12(11):e1006026. PMID: 27898737.
        View in: PubMed
      3. Reardon B, Beliakova-Bethell N, Spina CA, Singhania A, Margolis DM, Richman DR, Woelk CH. Dose-responsive gene expression in suberoylanilide hydroxamic acid-treated resting CD4+ T cells. AIDS. 2015 Nov; 29(17):2235-44. PMID: 26258524.
        View in: PubMed
      4. White CH, Johnston HE, Moesker B, Manousopoulou A, Margolis DM, Richman DD, Spina CA, Garbis SD, Woelk CH, Beliakova-Bethell N. Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency. Antiviral Res. 2015 Nov; 123:78-85. PMID: 26343910.
        View in: PubMed
      5. Beliakova-Bethell N, Jain S, Woelk CH, Witt MD, Sun X, Lada SM, Spina CA, Goicoechea M, Rought SE, Haubrich R, Dubé MP. Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression. Antiviral Res. 2014 Jul; 107:42-9. PMID: 24769244.
        View in: PubMed
      6. Massanella M, Singhania A, Beliakova-Bethell N, Pier R, Lada SM, White CH, Pérez-Santiago J, Blanco J, Richman DD, Little SJ, Woelk CH. Differential gene expression in HIV-infected individuals following ART. Antiviral Res. 2013 Nov; 100(2):420-8. PMID: 23933117.
        View in: PubMed
      7. Beliakova-Bethell N, Zhang JX, Singhania A, Lee V, Terry VH, Richman DD, Spina CA, Woelk CH. Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells. AIDS. 2013 Jan 2; 27(1):29-37. PMID: 23221426.
        View in: PubMed
      8. Wie SH, Du P, Luong TQ, Rought SE, Beliakova-Bethell N, Lozach J, Corbeil J, Kornbluth RS, Richman DD, Woelk CH. HIV downregulates interferon-stimulated genes in primary macrophages. J Interferon Cytokine Res. 2013 Feb; 33(2):90-5. PMID: 23276142.
        View in: PubMed
      9. Clemens K, Bilanchone V, Beliakova-Bethell N, Larsen LS, Nguyen K, Sandmeyer S. Sequence requirements for localization and packaging of Ty3 retroelement RNA. Virus Res. 2013 Feb; 171(2):319-31. PMID: 23073180.
        View in: PubMed
      10. Woelk CH, Beliakova-Bethell N, Goicoechea M, Zhao Y, Du P, Rought SE, Lozach J, Pérez-Santiago J, Richman DD, Smith DM, Little SJ. Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery. AIDS. 2010 Jan 16; 24(2):217-22. PMID: 19952713.
        View in: PubMed
      11. Beliakova-Bethell N, Terry LJ, Bilanchone V, DaSilva R, Nagashima K, Wente SR, Sandmeyer S. Ty3 nuclear entry is initiated by viruslike particle docking on GLFG nucleoporins. J Virol. 2009 Nov; 83(22):11914-25. PMID: 19759143.
        View in: PubMed
      12. Larsen LS, Beliakova-Bethell N, Bilanchone V, Zhang M, Lamsa A, Dasilva R, Hatfield GW, Nagashima K, Sandmeyer S. Ty3 nucleocapsid controls localization of particle assembly. J Virol. 2008 Mar; 82(5):2501-14. PMID: 18094177.
        View in: PubMed
      13. Larsen LS, Zhang M, Beliakova-Bethell N, Bilanchone V, Lamsa A, Nagashima K, Najdi R, Kosaka K, Kovacevic V, Cheng J, Baldi P, Hatfield GW, Sandmeyer S. Ty3 capsid mutations reveal early and late functions of the amino-terminal domain. J Virol. 2007 Jul; 81(13):6957-72. PMID: 17442718.
        View in: PubMed
      14. Beliakova-Bethell N, Beckham C, Giddings TH, Winey M, Parker R, Sandmeyer S. Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components. RNA. 2006 Jan; 12(1):94-101. PMID: 16373495.
        View in: PubMed
      15. Irwin B, Aye M, Baldi P, Beliakova-Bethell N, Cheng H, Dou Y, Liou W, Sandmeyer S. Retroviruses and yeast retrotransposons use overlapping sets of host genes. Genome Res. 2005 May; 15(5):641-54. PMID: 15837808.
        View in: PubMed
      16. Aye M, Irwin B, Beliakova-Bethell N, Chen E, Garrus J, Sandmeyer S. Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae. Genetics. 2004 Nov; 168(3):1159-76. PMID: 15579677.
        View in: PubMed
      17. Nymark-McMahon MH, Beliakova-Bethell N, Darlix JL, Le Grice SF, Sandmeyer SB. Ty3 integrase is required for initiation of reverse transcription. J Virol. 2002 Mar; 76(6):2804-16. PMID: 11861848.
        View in: PubMed
      Nadejda's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _